Pharmacy groups want the FDA to take a uniform approach to risk management of prescription drugs.
E. Coli Vaccine Candidate Fails to Demonstrate Efficacy in Phase 3 Trial
Investigators note there were no safety signals related to the vaccine candidate, and participants who developed E. coli disease received treatment and care.
Pharmacists as the Authority on Ultra-High-Cost Drugs
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
FDA Grants Fast Track Designation to Cannabis Withdrawal Syndrome Therapy
A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
2025 ACIP Immunization Schedules
More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.
Tirzepatide Facilitates Greater Weight Loss, Strongest Antihypertensive Effects
For weight loss and antihypertensive effects on systolic and diastolic blood pressure, semaglutide also had increased effects.